ong-term effects of a lifestyle intervention on the health of children and teachers at cardiovascular risk in schools of disadvantaged communities in South Africa

Not Applicable

Completed

• Conditions: on-communicable diseases: obesity, hypertension, diabetes, dyslipidemia; Not Applicable

• Registration Number: ISRCTN15648510
• Lead Sponsor: Swiss National Science Foundation

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34610931/ protocol (added 21/10/2021) 2023 Results article in https://www.frontiersin.org/articles/10.3389/fpubh.2023.1199381/abstract (added 25/05/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38561742/ Qualitative descriptive study (added 03/04/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-17
• Study Completion: 2021-11-30
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 459

Inclusion Criteria

Current inclusion criteria as of 17/12/2020:
1. Children and teachers from the KaziBantu study population
2. Children aged approximately 10–13 years old (4th to 7th grade)
3. Teachers aged approximately 21–65 years old
4. Children identified for being at high-risk for non-communicable diseases defined as presenting at least:
4.1. Pre- or hypertension
4.2. Pre- or diabetes
4.3. Borderline or hypercholesterolemia
4.4. Overweight or obesity
5. Written informed consent by parent/guardian for children and by teachers

Previous inclusion criteria:
1. Children and teachers from the KaziBantu study population
2. Children aged approximately 10–13 years old (4th to 7th grade)
3. Teachers aged approximately 21–65 years old
4. Children and teachers identified for being at high-risk for non-communicable diseases defined as presenting at least:
4.1. Pre- or hypertension
4.2. Pre- or diabetes
4.3. Borderline or hypercholesterolemia
4.4. Overweight or obesity
5. Written informed consent by parent/guardian for children and by teachers

Exclusion Criteria

1. Participation in another clinical trial
2. Lack of written informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified